Search research articles
Contact Us
Filters
Showing results (381-390 of 409) with videos related to
Page
of 41
Sort By:
The British Journal of Surgery
|
September 29, 2025
Factors influencing locoregional recurrence rates in locally advanced rectal cancer after total neoadjuvant treatment versus chemoradiotherapy in the RAPIDO trial
Ilaria Prata, Max D Tanaka, Bengt Glimelius, et al.
Surgical Endoscopy
|
June 30, 2022
Risk of recurrence after local resection of T1 rectal cancer: a meta-analysis with meta-regression
Nik Dekkers, Hao Dang, Jolein van der Kraan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 30, 2020
First-in-Human Assessment of cRGD-ZW800-1, a Zwitterionic, Integrin-Targeted, Near-Infrared Fluorescent Peptide in Colon Carcinoma
Kim S de Valk, Marion M Deken, Henricus J M Handgraaf, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 5, 2014
Gene expression profiles in circulating tumor cells to predict prognosis in metastatic breast cancer patients
B Mostert, A M Sieuwerts, J Kraan, et al.
Nuclear Medicine Communications
|
May 3, 2023
Baseline and early digital [ 18 F]FDG PET/CT and multiparametric MRI contain promising features to predict response to neoadjuvant therapy in locally advanced rectal cancer patients: a pilot study
Floris A Vuijk, Shirin Feshtali Shahbazi, Wyanne A Noortman, et al.
Cancer Letters
|
March 24, 2015
Gene expression profiles of circulating tumor cells versus primary tumors in metastatic breast cancer
Wendy Onstenk, Anieta M Sieuwerts, Marleen Weekhout, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 11, 2026
Real-World Impact of UGT1A1 Genotype-Guided Irinotecan Dosing on Severe Toxicity and Hospitalization: A Multicenter Study
Niels Heersche, Sofía L J Peeters, Doortje Böhm, et al.
Nature Genetics
|
June 30, 2019
A genetics-led approach defines the drug target landscape of 30 immune-related traits
Hai Fang, , Hans De Wolf, et al.
The Lancet Regional Health. Europe
|
March 4, 2026
Survival of patients with colorectal or pancreatic cancer who received <i>UGT1A1</i> genotype-guided dosing of irinotecan in the Netherlands (2017-2024): a retrospective, multicentre cohort study
Sofía L J Peeters, Niels Heersche, Doortje Böhm, et al.
Annals of Internal Medicine
|
April 19, 2016
Long-Term Outcomes of Patients With Recent-Onset Rheumatoid Arthritis After 10 Years of Tight Controlled Treatment: A Randomized Trial
Iris M Markusse, Gülsah Akdemir, Linda Dirven, et al.
Page
of 41
Search research articles
Search
Showing results (381-390 of 409) with videos related to
Sort By:
Page
of 41
The British Journal of Surgery
|
September 29, 2025
Factors influencing locoregional recurrence rates in locally advanced rectal cancer after total neoadjuvant treatment versus chemoradiotherapy in the RAPIDO trial
Ilaria Prata, Max D Tanaka, Bengt Glimelius, et al.
Surgical Endoscopy
|
June 30, 2022
Risk of recurrence after local resection of T1 rectal cancer: a meta-analysis with meta-regression
Nik Dekkers, Hao Dang, Jolein van der Kraan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 30, 2020
First-in-Human Assessment of cRGD-ZW800-1, a Zwitterionic, Integrin-Targeted, Near-Infrared Fluorescent Peptide in Colon Carcinoma
Kim S de Valk, Marion M Deken, Henricus J M Handgraaf, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 5, 2014
Gene expression profiles in circulating tumor cells to predict prognosis in metastatic breast cancer patients
B Mostert, A M Sieuwerts, J Kraan, et al.
Nuclear Medicine Communications
|
May 3, 2023
Baseline and early digital [ 18 F]FDG PET/CT and multiparametric MRI contain promising features to predict response to neoadjuvant therapy in locally advanced rectal cancer patients: a pilot study
Floris A Vuijk, Shirin Feshtali Shahbazi, Wyanne A Noortman, et al.
Cancer Letters
|
March 24, 2015
Gene expression profiles of circulating tumor cells versus primary tumors in metastatic breast cancer
Wendy Onstenk, Anieta M Sieuwerts, Marleen Weekhout, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 11, 2026
Real-World Impact of UGT1A1 Genotype-Guided Irinotecan Dosing on Severe Toxicity and Hospitalization: A Multicenter Study
Niels Heersche, Sofía L J Peeters, Doortje Böhm, et al.
Nature Genetics
|
June 30, 2019
A genetics-led approach defines the drug target landscape of 30 immune-related traits
Hai Fang, , Hans De Wolf, et al.
The Lancet Regional Health. Europe
|
March 4, 2026
Survival of patients with colorectal or pancreatic cancer who received <i>UGT1A1</i> genotype-guided dosing of irinotecan in the Netherlands (2017-2024): a retrospective, multicentre cohort study
Sofía L J Peeters, Niels Heersche, Doortje Böhm, et al.
Annals of Internal Medicine
|
April 19, 2016
Long-Term Outcomes of Patients With Recent-Onset Rheumatoid Arthritis After 10 Years of Tight Controlled Treatment: A Randomized Trial
Iris M Markusse, Gülsah Akdemir, Linda Dirven, et al.
Page
of 41